Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2017024496
pages 1023-1027

Profiles of Little-Known Medicinal Polypores: Earliella scabrosa (Agaricomycetes)

Ivan V. Zmitrovich
V.L. Komarov Botanical Institute, Russian Academy of Sciences Prof. Popova St. 2, St. Petersburg, 197376, Russia
Oleg N. Ezhov
N. Laverov Federal Center for Integrated Arctic Research, Arkhangelsk, Russia
Kiran R. Ranadive
Waghire College, Saswad, Tal-Purandar, District-Pune, Maharashtra, India
Solomon P. Wasser
N.G. Kholodny Institute of Botany, NAS of Ukraine, 2 Tereshchenkovskaya Str., Kiev 01004, Ukraine; International Center for Cryptogamic Plants and Fungi, Institute of Evolution, University of Haifa, Mount Carmel, Haifa, Israel

RESUMO

The purpose of this study was to comprehensively characterize a little-known polypore that has recently been found to possess anticancer activity and thus can also be used in targeted cancer therapy. Earliella scabrosa is a polypore with pantropical distribution and can be found in rainforests in both the Eastern and Western Hemispheres. Some reports have described its antioxidant properties and free radical scavenging ability. Moreover, isocoumarin, which has been successfully used in targeted cancer therapy, was found in extracts of this fungus. We recommend further research of E. scabrosa so that more details of its health benefits could be used in mycotherapy.


Articles with similar content:

Profiles of Little-Known Medicinal Polypores: Funalia trogii (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 7
Margarita A. Bondartseva, Solomon P. Wasser, Ivan V. Zmitrovich, Oleg N. Ezhov, Stanislav P. Arefyev
Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine’s Drug Conjugates on Cancer Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 1
Sathish Dyawanapelly, Animesh Kumar, Manish K. Chourasia
Telomerase Inhibitory Effects of Medicinal Mushrooms and Lichens, and their Anticancer Activity
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 1
Baojun Xu, Chantian Li, Changkeun Sung
The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 10
Martina Cizmarikova
Apoptotic Effect of Taiwanofungus salmoneus (Agaricomycetes) Mycelia and Solid-State Fermented Products on Cancer Cells
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 9
Jeng-Leun Mau, Yu-Chieh Lin, Rao-Chi Chien